Home Study CME Enrollment Form

Home Study CME Enrollment Form Program Description and Objectives: The Journal of Urology®Home Study Course is a comprehensive learning activity developed by a team of educators, academicians and clinicians. After completing the program, urologists will be able to demonstrate an increase in or affirmation of their knowledge of clinical medicine. They will also be able to evaluate the appropriateness of clinical data and apply it to their practice and the provision of patient care. Program Format: Two volumes of the The Journal of Urology® are published annually. Each volume is comprised of 6 issues. Five clinically relevant articles are selected by the editor to be offered for CME in each issue of The Journal. For CME credit, the participant must read the articles and answer 5 related questions on the examination; enroll in the home study program; and choose to submit answers either online or on a paper answer sheet that will be sent to you with a return envelope. Accreditation: The American Urological Association Education and Research, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. The American Urological Association Education and Research, Inc. takes responsibility for the content, quality and scientific integrity of this CME activity. CME Credit: The American Urological Association Education and Research, Inc. designates this Journal educational activity for a maximum of 24.0 category 1 credits toward the AMA Physician’s Recognition Award. Completion of each test and a score of 80% or above qualify for 2 credits of Category 1 CME Credit with up to a maximum of 24 credits annually. Each physician should claim only those credits that he/she actually spent on this educational activity. Estimated time to complete activity is 2 hours. AUA Disclosure Policy: As a provider accredited by the ACCME, the American Urological Association Education and Research, Inc., must insure balance, independence, objectivity and scientific rigor in all its activities. All faculty participating in an educational activity provided by the American Urological Association Education and Research, Inc. are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The Program Planners and Scientific Planning Committee must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses are discussed, these are also indicated. Program Enrollment: There are 3 convenient ways to enroll in The Journal of Urology® Home Study Course. ● Complete the form below and return by MAIL including a check or credit card information ● Complete the form below and return by FAX including your credit card information ● Enroll online at www.auanet.org. Choose Catalog/Products. Then, choose Home Study/CME and click on Print and then on Journal of Urology Home Study. ● You will need your AUA identification number, password and credit card to purchase this home study product. For any of these enrollment options you must choose one method to submit your home study answers– either online or by mail on a provided paper answer sheet. The cost for the home study is $30 each for Volumes 175 and 176 in 2006 ($60 for both volumes). Previous home study volumes may be ordered by calling 1-866-746-4282, ext 3747. See page 1179 for questionnaire

The Journal of Urology® Home Study Program Enrollment Form Volume # $30 subscription cost per volume Maximum of 24 Category 1 credits annually Name: Address:

City:

State:

( ) Check enclosed for $ Charge to

( ) VISA

Zip:

payable to: American Urological Association Education and Research, Inc.®

( ) MasterCard

( ) AMEX

Card Number:

Exp. Date:

Signature: Please mail or fax registration form to:

American Urological Association Education and Research, Inc.® 1000 Corporate Blvd. Linthicum, MD 21090 Telephone: 1-410-689-3934 Fax: 1-410-689-3937

0022-5347/06/1753-1178/0 THE JOURNAL OF UROLOGY® Copyright © 2006 by AMERICAN UROLOGICAL ASSOCIATION

1178

Vol. 175, 1178-1179, March 2006 Printed in U.S.A. DOI:10.1016/S0022-5347(05)00638-5

1179

CME QUESTIONS FOR MARCH 2006 ISSUE OF THE JOURNAL OF UROLOGY 1.

EVIDENCE TO SUPPORT A CONTINUED STAGE MIGRATION AND DECREASE IN PROSTATE CANCER SPECIFIC MORTALITY (vol. 175, pp. 907–912) Of all men with prostate specific antigen (PSA) failure the proportion with rapid rises in PSA (ie PSA doubling time less than 3 months) has done what over the last decade as PSA has been more widely used? a) b) c) d) e)

2.

increased significantly decreased significantly remained the same increased numerically but not significantly decreased numerically but not significantly

NOVEL APPROACH OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 DETECTION IN NONINVASIVE AND INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER (vol. 175, pp. 875– 880) The therapeutic target for Herceptin® antibody therapy is: a) b) c) d) e)

3.

transforming growth factor-␤ human epidermal growth factor receptor 2 epidermal growth factor receptor E-cadherin vascular endothelial growth factor

DO THE BENEFITS OF FINASTERIDE OUTWEIGH THE RISKS IN THE PROSTATE CANCER PREVENTION TRIAL? (vol. 175, pp. 934 –938) Which of the following factors is not associated with the long-term benefits of preventing prostate cancer with finasteride: a) b) c) d) e)

4.

cancer grade protocol directed end of study biopsies patient age when starting treatment prostate volume cancer incidence

THE CASE FOR EARLY CYSTECTOMY IN THE TREATMENT OF NONMUSCLE INVASIVE MICROPAPILLARY BLADDER CARCINOMA (vol. 175, pp. 881– 885) The optimal management for a pathological diagnosis of micropapillary bladder cancer invading the lamina propria is: a) b) c) d) e)

5.

observation, since micropapillary diagnosis indicates indolent behavior intravesical therapy with interferon intravesical therapy with bacillus Calmette-Guerin radical cystectomy radiation therapy, since micropapillary disease is incurable

TRANSOBTURATOR VERSUS TRANSABDOMINAL MID URETHRAL SLINGS: A MULTI-INSTITUTIONAL COMPARISON OF OBSTRUCTIVE VOIDING COMPLICATIONS (vol. 175, pp. 1014 –1017) Compared with transabdominal mid urethral polypropylene slings, transobturator slings are associated with: a) b) c) d) e)

superior efficacy lower rate of vaginal tape erosion increased risk of bladder injury increased risk of bowel injury lower risk of obstructive voiding symptoms

Publication Date: March 2006 Expiration Date: March 2009